MS
OKYO

Maven Securities’s OKYO Pharma OKYO Stock Holding History

Maven Securities’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
809,317
-366,218
-31% -$587K 0.02% 263
2026
Q1 		$1.89M Buy
+1,175,535
New +$2.28M 0.04% 268

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Maven Securities's OKYO Position: Q2 2026 in Review

Maven Securities reduced its OKYO Pharma (OKYO) stake by 31% in Q2 2026, selling an estimated $587K and leaving 809,317 shares worth $1.21M. The position accounts for 0.02% of the portfolio, ranked #263.

Maven Securities first reported a position in OKYO in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.89M in Q1 2026. 19 funds tracked by Wall St. Rank hold OKYO as of Q2 2026.

  • Maven Securities held 809,317 shares of OKYO Pharma worth $1.21M as of Q2 2026.
  • Maven Securities sold 366,218 OKYO Pharma shares in Q2 2026, an estimated $587K.
  • OKYO Pharma made up 0.02% of Maven Securities's portfolio in Q2 2026, its #263 holding.
  • Maven Securities first reported a position in OKYO Pharma in Q1 2026 and has held it in 2 quarters since.
  • Maven Securities's OKYO Pharma position peaked at $1.89M in Q1 2026.
  • 19 funds tracked by Wall St. Rank held OKYO Pharma as of Q2 2026.

Based on Maven Securities's 13F filing for Q2 2026, filed 14 Aug 2026.